Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Director Acquires $101,010.00 in Stock

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Director Catherine Cusack purchased 7,000 shares of the firm’s stock in a transaction dated Wednesday, May 22nd. The stock was purchased at an average cost of $14.43 per share, with a total value of $101,010.00. Following the acquisition, the director now directly owns 46,385 shares in the company, valued at $669,335.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Sabra Health Care REIT Trading Up 1.9 %

Shares of NASDAQ:SBRA opened at $14.42 on Friday. The company’s 50-day moving average price is $14.25 and its two-hundred day moving average price is $14.08. The company has a debt-to-equity ratio of 0.89, a current ratio of 4.33 and a quick ratio of 4.33. Sabra Health Care REIT, Inc. has a one year low of $10.30 and a one year high of $14.92. The stock has a market capitalization of $3.34 billion, a PE ratio of 72.10, a price-to-earnings-growth ratio of 2.43 and a beta of 1.17.

Sabra Health Care REIT Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, May 31st. Stockholders of record on Monday, May 20th will be issued a $0.30 dividend. The ex-dividend date is Friday, May 17th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 8.32%. Sabra Health Care REIT’s payout ratio is 600.00%.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on SBRA. Deutsche Bank Aktiengesellschaft began coverage on shares of Sabra Health Care REIT in a research note on Tuesday, January 30th. They issued a “buy” rating and a $21.00 target price for the company. Wedbush reaffirmed an “outperform” rating and issued a $17.00 target price on shares of Sabra Health Care REIT in a research note on Thursday, February 29th. Finally, Scotiabank upped their target price on shares of Sabra Health Care REIT from $14.00 to $15.00 and gave the stock a “sector perform” rating in a research note on Wednesday, May 15th. Six research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat, Sabra Health Care REIT presently has an average rating of “Moderate Buy” and a consensus target price of $15.71.

Institutional Investors Weigh In On Sabra Health Care REIT

A number of institutional investors and hedge funds have recently modified their holdings of the company. Vanguard Group Inc. raised its holdings in shares of Sabra Health Care REIT by 2.5% in the 1st quarter. Vanguard Group Inc. now owns 34,972,611 shares of the real estate investment trust’s stock valued at $516,545,000 after purchasing an additional 838,654 shares during the period. Principal Financial Group Inc. lifted its stake in Sabra Health Care REIT by 0.4% in the 1st quarter. Principal Financial Group Inc. now owns 21,571,121 shares of the real estate investment trust’s stock valued at $318,605,000 after purchasing an additional 83,842 shares during the last quarter. JPMorgan Chase & Co. lifted its stake in Sabra Health Care REIT by 709.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 13,504,420 shares of the real estate investment trust’s stock valued at $188,252,000 after purchasing an additional 11,835,109 shares during the last quarter. Janus Henderson Group PLC lifted its stake in Sabra Health Care REIT by 2.9% in the 1st quarter. Janus Henderson Group PLC now owns 5,199,682 shares of the real estate investment trust’s stock valued at $76,701,000 after purchasing an additional 145,548 shares during the last quarter. Finally, LSV Asset Management lifted its stake in Sabra Health Care REIT by 2.5% in the 4th quarter. LSV Asset Management now owns 4,385,615 shares of the real estate investment trust’s stock valued at $62,583,000 after purchasing an additional 107,266 shares during the last quarter. 99.40% of the stock is owned by institutional investors.

About Sabra Health Care REIT

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.